USPSTF Discourages Screening Asymptomatic Women for Ovarian Cancer
The United States Preventive Services Task Force has reaffirmed its 2004 recommendation statement against routine screening of asymptomatic women for ovarian cancer.
Gynecologic Cancers
Cytologically Benign Endometrial Cells Associated with Hyperplasia and Cancer After Age 40
CBEC assessment might be justified for premenopausal women over age 40 years — even when abnormal bleeding is not established.
Frequent Ovarian Cancer Screening Does Not Cause Sustained Psychological Harm
Frequent ovarian cancer screening does not increase anxiety or depression, but can increase the risk of a woman dropping out of the screening program soon after an abnormal test result.
FOXM1 Promotes Tumor Cell Invasion and Predicts Poor Survival in Early-Stage Cervical Cancer
Expression of the forkhead box M1 (FOXM1) transcription factor is associated with poor prognosis in early-stage cervical squamous cell carcinoma.
Uterine Cancer Histopathologic Differences Alone Might Explain Ethnic Disparities in Survival
Histological subtypes appear to explain ethnic disparities in uterine cancer survival, according to a retrospective, single-institution study.
Type 2 Diabetes Mellitus Does Not Up Epithelial Ovarian Cancer Risk
According to a study, type 2 diabetes mellitus is not associated with an increased risk of epithelial ovarian cancer.
LRP1B Contributes to Chemoresistance in HGSC Ovarian Cancer
LRP1B expression in women with high-grade serous cancer contributes to chemotherapy resistance.
Baseline HPV Test Predicts Cervical Cancer in Long Term
HPV test, compared with Pap, at baseline better predicts CIN3 at follow-up of 18 years.
BRCA2 Mutations Confer Survival Benefit in Ovarian Cancer
Patients with serous ovarian cancer BRCA2 mutations, but not BRCA1 mutations, have a survival advantage.
Severe Comorbidity Poor Prognostic Factor for Ovarian Cancer
(ChemotherapyAdvisor) – Among women with ovarian cancer, the elderly and those with comorbidity are less likely to receive optimal surgical and medical treatment, a study reported in Gynecologic Oncology online July 15. However, while age 70 years and older was not found to be an independent poor prognostic factor, severe comorbidity was, noted Trine Lembrecht…
- Loading...
Loading...
Next post in Gynecologic Cancer
Loading... 
Loading...